These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6198954)

  • 1. Interferon as a modifier of estrogen receptors.
    Dimitrov NV; Meyer CJ; Strander H; Einhorn S; Cantell K
    Ann Clin Lab Sci; 1984; 14(1):32-9. PubMed ID: 6198954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of sex steroid receptors in obstetrics and gynecology.
    Roberts DK; Van Sickle M; Kelly RW
    Obstet Gynecol Annu; 1983; 12():61-78. PubMed ID: 6866353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
    Murphy LJ; Murphy LC; Vrhovsek E; Sutherland RL; Lazarus L
    Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of liposome-encapsulated alpha- or beta-interferon on breast cancer cell lines.
    Coradini D; Pellizzaro C; Biffi A; Lombardi L; Pirronello E; Riva L; Di Fronzo G
    Anticancer Res; 1998; 18(1A):177-82. PubMed ID: 9568074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol induction of retinoic acid receptors in human breast cancer cells.
    Roman SD; Ormandy CJ; Manning DL; Blamey RW; Nicholson RI; Sutherland RL; Clarke CL
    Cancer Res; 1993 Dec; 53(24):5940-5. PubMed ID: 8261407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
    Kawai H; Li H; Chun P; Avraham S; Avraham HK
    Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD; Fang H; Xu J; Grimley PM; Rui H
    Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interferon-beta on steroid receptors, prostaglandins and enzymatic activities in human endometrial cancer.
    De Cicco Nardone F; Rossiello F; Iacopino F; Benedetto MT; Cinque B; Dell'Acqua S; Sica G
    Anticancer Res; 1996; 16(1):161-9. PubMed ID: 8615603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of alpha-, beta- and gamma-interferon on the growth of breast cancer cell lines.
    Coradini D; Biffi A; Pirronello E; Di Fronzo G
    Anticancer Res; 1994; 14(5A):1779-84. PubMed ID: 7531412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
    Rubin M; Fenig E; Rosenauer A; Menendez-Botet C; Achkar C; Bentel JM; Yahalom J; Mendelsohn J; Miller WH
    Cancer Res; 1994 Dec; 54(24):6549-56. PubMed ID: 7987855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fast and convenient method for determining estrogen receptor using rabbit uterus as a standard.
    Mukharji J; Zachariah NY; Chakmakjian ZH; Race GJ
    Cancer Res; 1983 Jul; 43(7):3143-6. PubMed ID: 6850623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytofluorometric analysis for estrogen receptors using fluorescent estrogen probes.
    Kute TE; Linville C; Barrows G
    Cytometry; 1983 Sep; 4(2):132-40. PubMed ID: 6685018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression.
    Rosenauer A; Nervi C; Davison K; Lamph WW; Mader S; Miller WH
    Cancer Res; 1998 Nov; 58(22):5110-6. PubMed ID: 9823320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity.
    Fan S; Ma YX; Wang C; Yuan RQ; Meng Q; Wang JA; Erdos M; Goldberg ID; Webb P; Kushner PJ; Pestell RG; Rosen EM
    Oncogene; 2001 Jan; 20(1):77-87. PubMed ID: 11244506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ; Zhu BT
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent sensitivity of human tumor cell lines to interferon and double-stranded RNA.
    Hubbell HR; Liu RS; Maxwell BL
    Cancer Res; 1984 Aug; 44(8):3252-7. PubMed ID: 6204744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of natural killing activity by lymphoblastoid interferon in cancer patients.
    Koren HS; Brandt CP; Tso CY; Laszlo J
    J Biol Response Mod; 1983; 2(2):151-65. PubMed ID: 6644332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
    Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
    Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.